#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Tourette's disorder Cerebral haemorrhage Haemophilia A with anti factor VIII SAPHO syndrome Andersen-Tawil syndrome B-cell lymphoma Arteriovenous malformation Myeloproliferative neoplasm Chronic lymphocytic leukaemia recurrent B-cell small lymphocytic lymphoma refractory Glycogen storage disease type I Penile cancer Brain injury Cutaneous calcification Behcet's syndrome More trials…

    Learn about Rare Diseases

    Rhabdoid tumour – Basic Information Prader-Willi syndrome Niemann-Pick disease – Basic Information Cerebral arteriovenous malformation haemorrhagic Uterine leiomyosarcoma – Diagnostics Myelodysplastic syndrome – Treatment Pleural mesothelioma malignant – Basic Information Andersen-Tawil syndrome – Life with Disease Alagille syndrome – Diagnostics Marginal zone lymphoma refractory More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Xenon (129Xe) Encorafenib Bupropion Hydrochloride Specific Nucleic Acid Sna-Xfsa Cerebrolysin Concentrate SECRETIN SYNTHETIC HUMAN Carvedilol Rhh646 Ozanimod Pervi-Fus Paracetamol Mva-209-Fsp-B1 MARALIXIBAT Sodium Nitroprusside Dihydrate Pirtobrutinib Gilteritinib Camlipixant Tirzepatide Riociguat Ondansetron Hydrochloride More therapies…

    Learn about Your Condition

    Abdominal wall pain Neuralgia Papilloma viral infection Ventricular tachycardia Optic ischaemic neuropathy Cutaneous lupus erythematosus Gallbladder cancer Chondrocalcinosis Arteriospasm coronary Vertebrobasilar stroke Biliary cancer metastatic Multiple system atrophy Biliary neoplasm Biotinidase deficiency Epstein-Barr virus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Universitetssykehuset Nord-Norge HF

Universitetssykehuset Nord-Norge HF

P. O. Box 100, Tromsø, 9038, Norway

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Revumenib
    • Azacitidine
    • Venetoclax
    Austria Belgium Denmark Estonia Finland France +8

  • Study Comparing Chemotherapy Options for Patients with Stage I Testicular Cancer: Bleomycin, Etoposide, Cisplatin vs. Carboplatin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Testicular seminoma (pure) stage I
    Investigated Drugs:
    • Bleomycin
    • Carboplatin
    • Cisplatin
    Norway Sweden

  • Study of drug combinations including cisplatin, carboplatin, doxorubicin, fluorouracil, vincristine, etoposide, irinotecan, gemcitabine, oxaliplatin and sorafenib for children with hepatoblastoma or hepatocellular carcinoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sorafenib
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Germany Ireland +4

  • Study on Betamethasone Sodium Phosphate to Prevent Asthma in Children with First-time Rhinovirus-induced Wheezing

    Recruiting

    3 1 1
    Investigated Diseases:
    • Bronchiolitis
    • Wheezing
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    Finland Norway Sweden

  • Study on Dalteparin Sodium and Enoxaparin Sodium for Preventing Blood Clots in Patients Undergoing Liver Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dalteparin Sodium
    • Enoxaparin Sodium
    Norway

  • Study on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Dabrafenib
    • Vorasidenib
    • Trametinib
    Norway

  • Study of drug combination therapy for patients with recurrent and primary refractory Ewing Sarcoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma recurrent
    • Extra-osseous Ewing’s sarcoma
    • Extra-osseous Ewing’s sarcoma metastatic
    Investigated Drugs:
    • Etoposide Phosphate
    • Anhydrous Docetaxel
    • Ifosfamide
    Austria Belgium Czechia Denmark Finland France +4

  • Study on the Effect of Amoxicillin in Preschool Children with Pneumonia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amoxicillin Trihydrate
    Norway

  • Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neonatal alloimmune thrombocytopenia
    Investigated Drugs:
    • Human Normal Immunoglobulin (Iv)
    • Nipocalimab
    • Prednisone
    Austria Belgium Germany Hungary Ireland Italy +5

  • Study of Mirikizumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium France Italy The Netherlands Norway +3
Previous Page
1 2 3 4 5 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!